USA Financial Formulas’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
USA Financial Formulas's EXEL Position: Q3 2026 in Review
USA Financial Formulas reduced its Exelixis (EXEL) stake by 94% in Q3 2026, selling an estimated $55.4K and leaving 61 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #339.
USA Financial Formulas first reported a position in EXEL in Q3 2023 and has held it in 9 quarters since. The position peaked at $367K in Q1 2025. 251 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.
- USA Financial Formulas held 61 shares of Exelixis worth $3.56K as of Q3 2026.
- USA Financial Formulas sold 993 Exelixis shares in Q3 2026, an estimated $55.4K.
- Exelixis made up ﹤0.01% of USA Financial Formulas's portfolio in Q3 2026, its #339 holding.
- USA Financial Formulas first reported a position in Exelixis in Q3 2023 and has held it in 9 quarters since.
- USA Financial Formulas's Exelixis position peaked at $367K in Q1 2025.
- 251 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.
Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.